Remimazolam Clinical Trials

7 recruiting

Remimazolam Trials at a Glance

8 actively recruiting trials for remimazolam are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Hangzhou, and Pittsburgh. Lead sponsors running remimazolam studies include Keith M Vogt, Maternal and Child Health Hospital of Hubei Province, and First Affiliated Hospital of Zhejiang University.

Browse remimazolam trials by phase

Treatments under study

About Remimazolam Clinical Trials

Looking for clinical trials for Remimazolam? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Remimazolam trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Remimazolam clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Early Phase 1

Remimazolam NeuroImaging

PainAnesthesiaRemimazolam
Keith M Vogt60 enrolled1 locationNCT07290205
Recruiting
Not Applicable

Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam

Elderly PatientsRemimazolamFlumazenil Adverse Reaction+1 more
Pusan National University Yangsan Hospital24 enrolled1 locationNCT05939674
Recruiting
Not Applicable

Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation

EsketamineDexmedetomidineRemimazolam
Maternal and Child Health Hospital of Hubei Province150 enrolled1 locationNCT07050212
Recruiting
Phase 4

Remimazolam and Emergence Delirium in Pediatrics

RemimazolamEmergence DeliriumNeurosurgery+2 more
Peking University First Hospital248 enrolled2 locationsNCT07046364
Recruiting
Not Applicable

Remimazolam Besylate in Sedation of Postcardioperative Patients

Mechanical VentilationRemimazolamSedation+3 more
First Affiliated Hospital of Zhejiang University120 enrolled1 locationNCT06716840
Recruiting

The EEG Study Under Remimazolam Anesthesia in Children

RemimazolamElectroencephalography
Second Affiliated Hospital of Wenzhou Medical University60 enrolled1 locationNCT06698705
Recruiting

Study on the Feelings of Euphoria Caused by Remimazolam During Gastroscopy and Colonoscopy and Their Related Factors

EuphoriaRemimazolam BesylateGastrointestinal Endoscopy
Zhangjie Yu305 enrolled1 locationNCT06721195
Recruiting
Not Applicable

Remimazolam for Postoperative Atrial Fibrillation

Coronary Artery Bypass GraftingRemimazolam
Yangzhou University50 enrolled1 locationNCT05891145